Ascendis Pharma (ASND) SVP Mads Bodenhoff Exercises Options, Sells 3,000 Shares

What Happened

• Mads Bodenhoff, SVP & Principal Accounting Officer of Ascendis Pharma (ASND), exercised 3,000 derivative securities at $110.00 per share (cost $330,000) and then sold 3,000 common shares in the open market at $270.19 per share for total proceeds of $810,570 on 2026-09-08. The filing also records a related derivative conversion/disposition of 3,000 units at $0.00 (see footnote).

Key Details

• Transaction dates: 2026-09-08 (exercise and sale); filing date: 2026-09-09 (timely).
• Exercise: 3,000 shares at $110.00 — total cash paid $330,000.
• Sale: 3,000 shares at $270.19 — total proceeds $810,570.
• Report shows a derivative disposition of 3,000 at $0.00 (likely the surrendered/converted warrants).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote F1: the warrants vested 25% on Oct 11, 2023 and thereafter in 36 equal monthly installments.

Context

• This pattern (exercise followed by an immediate open-market sale) is effectively a cashless exercise: the insider exercised vested options/warrants, then sold the resulting shares. Net pre-tax proceeds ≈ $480,570 (sale proceeds minus exercise cost), before fees and taxes.
• The filing is informational and does not indicate the insider’s motivations.